GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 121 filers reported holding GERON CORP in Q4 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,662,516 | -20.2% | 4,557,790 | +20.8% | 0.00% | 0.0% |
Q2 2023 | $12,111,227 | +39.0% | 3,772,968 | -6.0% | 0.00% | +50.0% |
Q1 2023 | $8,710,662 | +2121.4% | 4,014,130 | +2377.3% | 0.00% | – |
Q4 2022 | $392,128 | +3.2% | 162,036 | -0.4% | 0.00% | – |
Q3 2022 | $380,000 | +63.8% | 162,616 | +8.2% | 0.00% | – |
Q2 2022 | $232,000 | +52.6% | 150,327 | +35.1% | 0.00% | – |
Q1 2022 | $152,000 | +13.4% | 111,304 | +1.7% | 0.00% | – |
Q4 2021 | $134,000 | -23.0% | 109,406 | -14.0% | 0.00% | – |
Q3 2021 | $174,000 | +8.8% | 127,148 | +12.0% | 0.00% | – |
Q2 2021 | $160,000 | +16.8% | 113,566 | +31.7% | 0.00% | – |
Q1 2021 | $137,000 | -51.6% | 86,229 | -51.6% | 0.00% | – |
Q4 2020 | $283,000 | +19.9% | 178,059 | +31.2% | 0.00% | – |
Q3 2020 | $236,000 | -22.4% | 135,735 | -2.5% | 0.00% | – |
Q2 2020 | $304,000 | +66.1% | 139,281 | -9.7% | 0.00% | – |
Q1 2020 | $183,000 | +43.0% | 154,299 | +99.4% | 0.00% | – |
Q1 2019 | $128,000 | +80.3% | 77,364 | +9.7% | 0.00% | – |
Q4 2018 | $71,000 | -51.4% | 70,510 | -14.9% | 0.00% | – |
Q3 2018 | $146,000 | -31.8% | 82,825 | +32.6% | 0.00% | – |
Q2 2018 | $214,000 | -2.7% | 62,473 | +20.8% | 0.00% | – |
Q1 2018 | $220,000 | +161.9% | 51,735 | +10.3% | 0.00% | – |
Q4 2017 | $84,000 | -16.8% | 46,893 | +1.1% | 0.00% | – |
Q3 2017 | $101,000 | -16.5% | 46,399 | +6.2% | 0.00% | – |
Q2 2017 | $121,000 | +57.1% | 43,700 | +28.6% | 0.00% | – |
Q1 2017 | $77,000 | +26.2% | 33,989 | +15.9% | 0.00% | – |
Q4 2016 | $61,000 | -1.6% | 29,330 | +7.4% | 0.00% | – |
Q3 2016 | $62,000 | -15.1% | 27,302 | +0.4% | 0.00% | – |
Q2 2016 | $73,000 | -95.5% | 27,193 | -95.1% | 0.00% | -100.0% |
Q1 2016 | $1,612,000 | -86.9% | 552,204 | -78.3% | 0.00% | -80.0% |
Q4 2015 | $12,289,000 | +159.7% | 2,539,088 | +129.6% | 0.01% | +150.0% |
Q2 2015 | $4,732,000 | +7786.7% | 1,105,661 | +3601.2% | 0.00% | – |
Q3 2014 | $60,000 | -95.5% | 29,873 | -92.7% | 0.00% | -100.0% |
Q2 2014 | $1,320,000 | +1785.7% | 411,118 | +1120.8% | 0.00% | – |
Q1 2014 | $70,000 | +191.7% | 33,676 | +577.6% | 0.00% | – |
Q4 2013 | $24,000 | +50.0% | 4,970 | +3.2% | 0.00% | – |
Q3 2013 | $16,000 | +128.6% | 4,818 | 0.0% | 0.00% | – |
Q2 2013 | $7,000 | – | 4,818 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 5,732,770 | $7,854,000 | 1.22% |
RA Capital Management | 30,126,299 | $41,273,000 | 0.57% |
NEA Management Company, LLC | 13,461,538 | $18,442,000 | 0.22% |
Virtus ETF Advisers LLC | 146,618 | $201,000 | 0.09% |
Forefront Analytics, LLC | 82,336 | $113,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 226,098 | $310,000 | 0.03% |
Summit X, LLC | 84,077 | $114,000 | 0.03% |
Poehling Capital Management, INC. | 53,000 | $73,000 | 0.02% |
Arnhold LLC | 154,700 | $212,000 | 0.02% |
Piscataqua Savings Bank | 12,500 | $17,000 | 0.02% |